Krystal Biotech Inc (KRYS)
164.75
+3.92
(+2.44%)
USD |
NASDAQ |
Dec 20, 16:00
165.06
+0.31
(+0.19%)
After-Hours: 20:00
Krystal Biotech Shareholders Equity (Quarterly): 885.85M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bioventus Inc | 148.74M |
| ADMA Biologics Inc | 231.89M |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Amicus Therapeutics Inc | 178.82M |
| Insmed Inc | 483.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 982.32M |
| Total Liabilities (Quarterly) | 96.47M |
| Current Ratio | 7.966 |